From The Analytical Scientist:
Inspired by the individuals on The Power List?
The University of Tasmania’s Emily Hilder features in this year’s Power List – she also appeared on the 2013 Power List of the Top 100 most influential analytical scientists. Here, Emily shares information on an ambitious new collaborative project – and outlines who she’s looking to work with.
Trajan Scientific and Medical’s hemaPEN® has been independently evaluated and the results of the study published in the Royal Society of Chemistry’s journal Analyst - selected for the cover of issue 17. hemaPEN demonstrated significant advantages for blood sampling to support better healthcare decision making.
Trajan Scientific and Medical has listed its hemaPEN® blood microsampling device with the U.S. Food and Drug Administration as Class I for therapeutic and in vitro diagnostic use. This follows the hemaPEN’s recent registration in May for supply in the EU and UK as a General IVD; as well as inclusion in the TGA’s ARTG (Australian Register of Therapeutic Goods) in February as a Class I IVD.